Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
Leukemia & Lymphoma|October 10, 2009
Historical aspects and milestones in the development of effective treatment for hairy cell leukemiaMartin S Tallman, Aaron PolliackCurrent Pharmaceutical Design|February 7, 2003
Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell supportYossi Cohen, Aaron Polliack, Arnon NaglerBritish Journal of Haematology|April 12, 2011
Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapyTamar Tadmor, Dina Attias, Aaron PolliackHematological Oncology|March 19, 2022
Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemiaStefano Molica, Constantine Tam, Aaron PolliackEuropean Journal of Haematology|June 14, 2002
Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphomaYossi Cohen, Gail Amir, Aaron PolliackLeukemia & Lymphoma|January 8, 2015
Novel therapeutic options for relapsed hairy cell leukemiaPreetesh Jain, Aaron Polliack, Farhad RavandiLeukemia & Lymphoma|November 23, 2020
Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyondSean Harrop, Aaron Polliack, Constantine S TamHaematologica|July 15, 2003
Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenanceYossi Cohen, Philippe Solal-Céligny, Aaron PolliackLeukemia Research|November 21, 2018
Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biologyAlina Klein, Aaron Polliack, Anat Gafter-GviliHematological Oncology|June 5, 2018
Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcomeAlina Klein, Aaron Polliack, Anat Gafter-GviliPageof 12